The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.

Sen. Cynthia Lummis, R-Wyo., discusses the United States’ artificial intelligence power push on ‘Making Money.’ UBS Private Wealth Management managing director Alli McCartney discusses the factors ...

Kristina Zucchi is an investment analyst and financial writer with 15+ years of experience managing portfolios and conducting equity research. Gordon Scott has been an active investor and technical ...